Replies to post #109495 on Regen BioPharma Inc (RGBP)

[29YEARINVESTOR]

Submitted 15 Mar 2022 Preclinical trials in Myelodysplastic syndromes in USA (IV) (Regen Biopharma pipeline)
10 Mar 2022 Preclinical development in Breast cancer and Myelodysplastic syndrome is ongoing USA

https://adisinsight.springer.com/drugs/800037634

I can’t wait for the FDA Fast Track!

[Bananaman73]

Lilly did act. They chose a different company and it fell flat on their face. The past articles tell us that region was in the running and since what they chose fell on his face it’s possible that region could be in the running again.